Research output: Contribution to journal › Article › peer-review
The spectrum of pathogenic variants of the ATP7B gene in Wilson disease in the Russian Federation. / Balashova, Mariya S.; Tuluzanovskaya, Inna G.; Glotov, Oleg S.; Glotov, Andrey S.; Barbitoff, Yury A.; Fedyakov, Mikhail A.; Alaverdian, Diana A.; Ivashchenko, Tatiana E.; Romanova, Olga V.; Sarana, Andrey M.; Scherbak, Sergey G.; Baranov, Vladislav S.; Filimonov, Marat I.; Skalny, Anatoly V.; Zhuchenko, Natalya A.; Ignatova, Tatiana M.; Asanov, Aliy Y.
In: Journal of Trace Elements in Medicine and Biology, Vol. 59, 126420, 05.2020.Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - The spectrum of pathogenic variants of the ATP7B gene in Wilson disease in the Russian Federation
AU - Balashova, Mariya S.
AU - Tuluzanovskaya, Inna G.
AU - Glotov, Oleg S.
AU - Glotov, Andrey S.
AU - Barbitoff, Yury A.
AU - Fedyakov, Mikhail A.
AU - Alaverdian, Diana A.
AU - Ivashchenko, Tatiana E.
AU - Romanova, Olga V.
AU - Sarana, Andrey M.
AU - Scherbak, Sergey G.
AU - Baranov, Vladislav S.
AU - Filimonov, Marat I.
AU - Skalny, Anatoly V.
AU - Zhuchenko, Natalya A.
AU - Ignatova, Tatiana M.
AU - Asanov, Aliy Y.
N1 - Funding Information: The study was supported by the Russian Science Foundation (No. 14-50-00069 ). Publisher Copyright: © 2019 Copyright: Copyright 2020 Elsevier B.V., All rights reserved.
PY - 2020/5
Y1 - 2020/5
N2 - Background. Wilson's disease (WD) is a rare inherited disorder caused by mutations in the ATP7B gene resulting in copper accumulation in different organs. However, data on ATP7B mutation spectrum in Russia and worldwide are insufficient and contradictory. The objective of the present study was estimation of the frequency of ATP7B gene mutations in the Russian population of WD patients. Materials and methods. 75 WDpatients were examined by next-generation sequencing (NGS). A targeted panel NimbleGen SeqCap EZ Choice: 151012_HG38_CysFib_EZ_HX3 (ROCHE)was designed for analysis of ATP7B gene and possible modifier genes. Retrospective assessment of a diagnostic WD score (Leipzig, 2001) was also performed. Results. 31 mutations in ATP7B gene were detected. Two most frequent mutations were c.3207C > A (51,85% of alleles) and c.3190 G > A (8,64% of alleles). Single rare mutations were detected in 29% of cases. In 96% cases mutations of both copies of the ATP7B were revealed. We also observed 3 novel potentially pathogenic variants which were not previously described (c.1870-8A > G, c.3655A > T (p.Ile1219Phe), c.3036dupC (p.Lys1013fs). For 25% of patients at the time of the manifestation the diagnosis WD could not be established using the earlier proposed diagnostic score. There was a remarkable delay in diagnosis for the majority of patients. Only 33% of patients WD was diagnosed in three months after the first symptoms, 29%patients - in 3–12 months, 30% – in 1–10 years, in 8% – more than 10 years. Generally, clinical appearance of WD may be rather variable at manifestation and genetic profiling at this step is the only way to confirm the presence of WD.
AB - Background. Wilson's disease (WD) is a rare inherited disorder caused by mutations in the ATP7B gene resulting in copper accumulation in different organs. However, data on ATP7B mutation spectrum in Russia and worldwide are insufficient and contradictory. The objective of the present study was estimation of the frequency of ATP7B gene mutations in the Russian population of WD patients. Materials and methods. 75 WDpatients were examined by next-generation sequencing (NGS). A targeted panel NimbleGen SeqCap EZ Choice: 151012_HG38_CysFib_EZ_HX3 (ROCHE)was designed for analysis of ATP7B gene and possible modifier genes. Retrospective assessment of a diagnostic WD score (Leipzig, 2001) was also performed. Results. 31 mutations in ATP7B gene were detected. Two most frequent mutations were c.3207C > A (51,85% of alleles) and c.3190 G > A (8,64% of alleles). Single rare mutations were detected in 29% of cases. In 96% cases mutations of both copies of the ATP7B were revealed. We also observed 3 novel potentially pathogenic variants which were not previously described (c.1870-8A > G, c.3655A > T (p.Ile1219Phe), c.3036dupC (p.Lys1013fs). For 25% of patients at the time of the manifestation the diagnosis WD could not be established using the earlier proposed diagnostic score. There was a remarkable delay in diagnosis for the majority of patients. Only 33% of patients WD was diagnosed in three months after the first symptoms, 29%patients - in 3–12 months, 30% – in 1–10 years, in 8% – more than 10 years. Generally, clinical appearance of WD may be rather variable at manifestation and genetic profiling at this step is the only way to confirm the presence of WD.
KW - ATP7B
KW - Degeneration
KW - Hepatocerebellar
KW - NGS
KW - Targeted panel
KW - Wilson's disease
KW - Hepatolenticular Degeneration/diagnosis
KW - Humans
KW - Male
KW - Gene Expression Profiling
KW - Genetic Variation/genetics
KW - Russia
KW - Polymerase Chain Reaction
KW - Adult
KW - Female
KW - High-Throughput Nucleotide Sequencing
KW - Mutation
KW - Copper-Transporting ATPases/genetics
KW - POPULATION
KW - GUIDELINES
KW - COPPER
KW - MOLECULAR PATHOLOGY
KW - MUTATIONS
KW - DIAGNOSIS
KW - DELINEATION
UR - http://www.scopus.com/inward/record.url?scp=85075449069&partnerID=8YFLogxK
UR - https://www.mendeley.com/catalogue/50555109-2d82-32ad-b48c-544db22a6790/
U2 - 10.1016/j.jtemb.2019.126420
DO - 10.1016/j.jtemb.2019.126420
M3 - Article
C2 - 31708252
AN - SCOPUS:85075449069
VL - 59
JO - Journal of Trace Elements in Medicine and Biology
JF - Journal of Trace Elements in Medicine and Biology
SN - 0946-672X
M1 - 126420
ER -
ID: 70417164